A61K 9/0073
Sprays or powders for inhalation
Official title: {Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy; (nasal sprays A61K9/0043; inhalation of vapours of volatile or heated drugs, e.g. essential oils or nicotine, A61K9/007; devices A61M)}
A61K9/0073 (Sprays or powders for inhalation) appears on 3,702 US grants and 6,921 published applications in this corpus.
Search patents in A61K- Granted patents
- 3,702
- Published applications
- 6,921
- Assignees
- 2,116
- Inventors
- 8,428
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 6 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 1 | 0 |
| 1982 | 4 | 0 |
| 1983 | 2 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 4 | 0 |
| 1987 | 6 | 0 |
| 1988 | 2 | 0 |
| 1989 | 10 | 0 |
| 1990 | 11 | 0 |
| 1991 | 5 | 0 |
| 1992 | 12 | 0 |
| 1993 | 17 | 0 |
| 1994 | 19 | 0 |
| 1995 | 14 | 0 |
| 1996 | 22 | 0 |
| 1997 | 50 | 0 |
| 1998 | 46 | 0 |
| 1999 | 65 | 0 |
| 2000 | 68 | 0 |
| 2001 | 65 | 43 |
| 2002 | 100 | 148 |
| 2003 | 99 | 280 |
| 2004 | 83 | 265 |
| 2005 | 53 | 236 |
| 2006 | 109 | 196 |
| 2007 | 64 | 217 |
| 2008 | 60 | 178 |
| 2009 | 57 | 214 |
| 2010 | 69 | 215 |
| 2011 | 80 | 190 |
| 2012 | 119 | 216 |
| 2013 | 118 | 184 |
| 2014 | 153 | 251 |
| 2015 | 114 | 290 |
| 2016 | 149 | 293 |
| 2017 | 176 | 321 |
| 2018 | 180 | 287 |
| 2019 | 188 | 345 |
| 2020 | 195 | 381 |
| 2021 | 217 | 463 |
| 2022 | 210 | 385 |
| 2023 | 185 | 442 |
| 2024 | 191 | 356 |
| 2025 | 172 | 324 |
| 2026 | 118 | 201 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Powder formulations for inhalation6 Oct 2026US 12,751,916 B2Christian-Albrechts-Universität zu Kiel
- Methods for delivery of psychedelic medications by inhalation and systems for performing the methods6 Oct 2026US 12,751,940 B2Cybin IRL Limited
- Bacteriophage compositions for treating Staphylococcus infection6 Oct 2026US 12,751,983 B2Armata Pharmaceuticals, Inc.
- Immunostimulatory adjuvants6 Oct 2026US 12,752,000 B2Orionis Biosciences BV
- Nanosuspension formulation for treatment of pulmonary fibrosis29 Sep 2026US 12,746,210 B2Federal University of Rio De Janeiro
- Steroid-cationic lipid compound and use thereof8 Oct 2026US 2026/0306406 A1Cansino (Shanghai) Biological Research Co., Ltd.
- Lipid nanoparticle for delivering nucleic acid drug, and preparation method therefor and use thereof8 Oct 2026US 2026/0306419 A1Cansino (Shanghai) Biological Research Co., Ltd.
- Inhaled statins as bronchodilators to improve lung function in respiratory diseases8 Oct 2026US 2026/0306477 A1Beth Israel Deaconess Medical Center, Inc.
- Inhaled adenovirus vector vaccine, preparation method therefor and use thereof8 Oct 2026US 2026/0306605 A1Cansino Biologics Inc.
- Dry powder formulations of epinephrine and associated methods1 Oct 2026US 2026/0294803 A1Belhaven BioPharma Inc.
Most cited
By later US patents
- Particles incorporating surfactants for pulmonary drug delivery537US 5,855,913 AMassachusetts Instite of Technology · 1999
- Aerodynamically light particles for pulmonary drug delivery468US 5,874,064 AMassachusetts Institute of Technology · 1999
- Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use358US 6,703,047 B2Incept, LLC · 2004
- Method and apparatus for administering dehydrated liposomes by inhalation353US 4,895,719 ALiposome Technology, Inc. · 1990
- Dispersible antibody compositions and methods for their preparation and use351US 6,019,968 AInhale Therapeutic Systems · 2000